During the past decade, Szpitale Pomorskie Sp. z o.o. conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 7 clinical trials were completed, i.e. on average, 17.5% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 7 clinical trials were completed. i.e. 28% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szpitale Pomorskie Sp. z o.o." #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "BeiGene" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "ADC Therapeutics S.A." with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpitale Pomorskie Sp. z o.o." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Szpitale Pomorskie Sp. z o.o." are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Small Lymphocytic Lymphoma" (3 trials), "Breast Cancer" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Szpitale Pomorskie Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Szpitale Pomorskie Sp. z o.o." are "Drug" (40 trials), "Other" (2 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Rituximab" (7 trials), "Bendamustine" (4 trials), "Amivantamab" (3 trials) and "Idelalisib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Szpitale Pomorskie Sp. z o.o." are 33 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Szpitale Pomorskie Sp. z o.o.". undefined are not yet recruiting, 14 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Szpitale Pomorskie Sp. z o.o., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Szpitale Pomorskie Sp. z o.o., 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Szpitale Pomorskie Sp. z o.o. has several departments that took part in Clinical trials: "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii" - 8 trials, "Szpital Morski im. PCK; Poradnia Onkologiczna" - 3 trials